CO73 Amivantamab Versus Real-World Clinical Practice in Europe and the US for Patients With Advanced Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

Autor:	C Chouaid, N Girard, A Kron, M Scheffler, C Knott, L Bosquet, J Trigo, S Viteri, M Sebastian, S Popat, N Rahhali, R Toueg, B Rodrigues, J Diels, CA Schioppa, J Cabrieto, J Sermon, NJ Perualila, N Erdmann, J Mielke, M Nematian-Samani, I Pfaira, C Martin-Fernandez, P Mahadevia, T Li, C Pick-Lauer, A Adamczyk, J Penton, J Wolf
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S32
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.09.152
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b96eebb8bd08ca951e7758986743303e https://doi.org/10.1016/j.jval.2022.09.152 Zobrazit plný text záznamu Full Text from ScienceDirect